Literature DB >> 12034795

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

P S Sachdev1, M Valenzuela, X L Wang, J C L Looi, H Brodaty.   

Abstract

The authors examined the association of total plasma homocysteine (Hcy) levels with measures of atrophy and white matter disease on MRI scans in 36 healthy elderly individuals. Hcy had a significant positive relationship with lateral ventricle-brain ratios in the anterior (r = 0.49) and middle (r = 0.43) ventricular regions as measures of central atrophy, but not with cortical atrophy or white matter hyperintensities. In a logistic regression analysis, elevated Hcy was a significant determinant of increased anterior ventricle-brain ratio (> or =0.34) after controlling for age, folate, B12, creatinine, and white matter disease (OR = 2.3; CI, 1.03-5.09).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034795     DOI: 10.1212/wnl.58.10.1539

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

Review 2.  Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?

Authors:  Hua Zhao; Ulf T Brunk; Brett Garner
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

3.  Possible treatment concepts for the levodopa-related hyperhomocysteinemia.

Authors:  Thomas Müller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-09

4.  Molecular rescue of DYRK1A overexpression in cystathionine beta synthase-deficient mouse brain by enriched environment combined with voluntary exercise.

Authors:  Benoit Souchet; Alizée Latour; Yuchen Gu; Fabrice Daubigney; Jean-Louis Paul; Jean-Maurice Delabar; Nathalie Janel
Journal:  J Mol Neurosci       Date:  2014-05-13       Impact factor: 3.444

Review 5.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 6.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

7.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

Review 8.  [Folate against hyperhomocysteinemia. A new approach for the prevention and therapy of alcoholism-associated disorders?].

Authors:  S Bleich; K Löffelholz; J Kornhuber
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

9.  Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study.

Authors:  Kirk I Erickson; Barbara L Suever; Ruchika Shaurya Prakash; Stanley J Colcombe; Edward McAuley; Arthur F Kramer
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

10.  Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Authors:  A David Smith; Stephen M Smith; Celeste A de Jager; Philippa Whitbread; Carole Johnston; Grzegorz Agacinski; Abderrahim Oulhaj; Kevin M Bradley; Robin Jacoby; Helga Refsum
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.